Since the summer, the U.S. has begun preparing about 10 million doses of a vaccine that they think will be effective against H5N1 bird flu. Federal officials have elected not to u ...
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
1d
MedPage Today on MSNWill the Egg Shortage Affect Flu Shots?Previous bird flu outbreaks and decades-old public health infrastructure have led industry to protect the hens used for ...
The Trump administration is looking to move away from depopulating entire flocks infected by Bird Flu. The focus will instead ...
BofA analyst Tim Anderson lowered the firm’s price target on Moderna (MRNA) to $32 from $34 and keeps an Underperform rating on the shares.
To that end, HHS has granted Moderna $590 million to help accelerate the development of a bird flu vaccine. The agency announced its backing of the Massachusetts-based pharmaceutical firm about 72 ...
In its fourth-quarter earnings report, Moderna’s revenue was down substantially from 2023. Separately, media reports reveal ...
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...
Moderna reported a wider loss than expected for the fourth quarter on Friday morning, and the drugmaker's sales forecast for ...
Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results